RBC Capital Remains a Hold on SAGE Therapeutics (SAGE)
RBC Capital analyst Brian Abrahams maintained a Hold rating on SAGE Therapeutics (SAGE – Research Report) on January 21 and set a price target ...
RBC Capital cuts Travelers stock price target to $268
RBC Capital Markets adjusted its outlook on Travelers Companies Inc. (NYSE:TRV) shares, reducing the price target to $268 from $273, while maintaining a Sector Perform rating. The $54.8 billion ...
RBC Capital Remains a Hold on Akamai (AKAM)
RBC Capital analyst Rishi Jaluria maintained a Hold rating on Akamai (AKAM – Research Report) on January 20 and set a price target of $100.00.
RBC Capital cuts Comerica price target to $76, maintains outperform
Comerica Incorporated (NYSE:CMA), headquartered in Dallas, Texas, is a financial services company with a focus on business banking, retail banking, and wealth management. With a market capitalization ...
cnbctv181d
Share Market Live
Frontline indices fall 1-2% on continued FII selling. Pain in broader markets reflects in market breadth; advance-decline ratio at 1:4. BSE-listed companies erase market cap of ₹7 lakh crore. Sensex ...